Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
		
    Clinical outcome after high-precision radiotherapy for skull base meningiomas: Pooled data from three large German centers for radiation oncology.
        
        Radiother. Oncol. 127, 274-279 (2018)
    
    
    
				Purpose: To evaluate outcome in patients with base of skull meningiomas treated with modern high precision radiation therapy (RT) techniques.Patients and methods: 927 patients from three centers were treated with either radiosurgery or fractionated high-precision RT for meningiomas. Treatment planning was based on CT and MRI following institutional guidelines. For radiosurgery, a median dose of 13 Gy was applied, for fractionated treatments, a median dose of 54 Gy in 1.8 Gy single fractions was prescribed. Follow-up included a clinical examination as well as contrast-enhanced imaging. All patients were followed up prospectively after radiotherapy in the three departments within a strict follow-up regimen. The median follow-up time was 81 months (range 1-348 months).Results: Median local control was 79 months (range 1-348 months). Local control (LC) was 98% at 1 year, 94% at 3 years, 92% at 5 years and 86% at 10 years. There was no difference between radiosurgery and fractionated RT. We analyzed the influence of higher doses on LC and could show that dose did not impact LC. Moreover, there was no difference between 54 Gy and 57.6 Gy in the fractionated group. Side effects were below 5% in both groups without any severe treatment-related complications.Discussion: Based on the pooled data analysis this manuscript provides a large series of meningiomas of the skull base treated with modern high precision RT demonstrating excellent local control and low rates of side effects. Such data support the recommendation of RT for skull base meningiomas in the interdisciplinary tumor board discussions. The strong role of RT must influence treatment recommendations keeping in mind the individual risk-benefit profile of treatment alternatives. (C) 2018 Elsevier B.V. All rights reserved.
			
			
		Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Times Cited
Scopus
Cited By
					
					Cited By
Altmetric
					
				4.942
					1.612
					10
					15
					
					
				Anmerkungen
				
					
						 
						
					
				
			
				
			
				Besondere Publikation
				
					
						 
					
				
			
			
			
				Auf Hompepage verbergern
				
					
						 
					
				
			
			
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
     
    
    
        Schlagwörter
        Meningioma ; Fsrt ; Imrt ; Outcome; Fractionated Stereotactic Radiotherapy; Nerve Sheath Meningioma; Local Tumor-control; Quality-of-life; Benign Meningiomas; Conformal Radiotherapy; Intracranial Meningioma; Vestibular Schwannomas; Malignant Meningiomas; Emission-tomography
    
 
     
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2018
    
 
     
    
        HGF-Berichtsjahr
        2018
    
 
    
    
        ISSN (print) / ISBN
        0167-8140
    
 
    
        e-ISSN
        1879-0887
    
 
     
     
     
	     
	 
	 
    
        Zeitschrift
        Radiotherapy and Oncology
    
 
		
    
        Quellenangaben
        
	    Band: 127,  
	    Heft: 2,  
	    Seiten: 274-279 
	    
	    
	
    
 
  
         
        
            Verlag
            Elsevier
        
 
        
            Verlagsort
            Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ireland
        
 
	
         
         
         
         
         
	
         
         
         
    
         
         
         
         
         
         
         
    
        Begutachtungsstatus
        Peer reviewed
    
 
    
        Institut(e)
        Institute of Radiation Medicine (IRM)
    
 
    
        POF Topic(s)
        30203 - Molecular Targets and Therapies
    
 
    
        Forschungsfeld(er)
        Radiation Sciences
    
 
    
        PSP-Element(e)
        G-501300-001
    
 
     
     	
    
    
        WOS ID
        WOS:000437107800018
    
    
        Scopus ID
        85044308100
    
    
        PubMed ID
        29598834
    
    
        Erfassungsdatum
        2018-06-20